SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-335903
Filing Date
2021-11-22
Accepted
2021-11-22 07:25:11
Documents
14
Period of Report
2021-11-19
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d258987d8k.htm   iXBRL 8-K 26279
2 EX-99.1 d258987dex991.htm EX-99.1 25198
6 GRAPHIC g258987g1120012103161.jpg GRAPHIC 3104
  Complete submission text file 0001193125-21-335903.txt   182522

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA dcph-20211119.xsd EX-101.SCH 2895
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE dcph-20211119_lab.xml EX-101.LAB 17374
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dcph-20211119_pre.xml EX-101.PRE 10955
7 EXTRACTED XBRL INSTANCE DOCUMENT d258987d8k_htm.xml XML 3227
Mailing Address 200 SMITH STREET WALTHAM MA 02451
Business Address 200 SMITH STREET WALTHAM MA 02451 781-209-6400
Deciphera Pharmaceuticals, Inc. (Filer) CIK: 0001654151 (see all company filings)

IRS No.: 200299725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38219 | Film No.: 211430147
SIC: 2834 Pharmaceutical Preparations